Figure 2.

Kaplan-Meier survival curves. A, Comparing by human immunodeficiency virus (HIV) status. Although HIV-infected individuals had a lower survival rate (84% vs 94% at 3 year follow-up), the difference was not statistically significant (log-rank P= .12). B, Comparing HIV-infected participants in different baseline CD4 strata with HIV-uninfected participants. Individuals with a baseline CD4 count ≤100 cells/mm³ had substantially lower survival (67%) at 3 year follow-up (P= .005). HIV-infected participants with baseline CD4 counts 101–200 and >200 cells/mm³ had survival similar to HIV-uninfected multidrug-resistant tuberculosis participants (log-rank P= .34 and P= .85, respectively).